Key Points Jupiter Neurosciences is enrolling patients in the Phase 2a RESET study of JOTROL for Parkinson’s disease. The randomized, placebo-controlled trial is expected to…
August 20, 2026
July 22, 2026
Access for All: How Late-Stage Neurology and Neuropsychiatry Are Widening the Path to Brain Health
Every year on July 22, the World Federation of Neurology and more than 125 national neurological societies mark World Brain Day, a global observance designed…
A DoW Partnership Puts AI-Powered EEG Inside Military PTSD and TBI Programs Firefly Neuroscience (Nasdaq: AIFF) is moving into defense healthcare. On March 26, 2026,…